Navigation Links
Johnson & Johnson to Webcast Annual Meeting of Shareholders
Date:4/16/2009

NEW BRUNSWICK, N.J., April 16 /PRNewswire-FirstCall/ -- Johnson & Johnson will webcast its Annual Meeting of Shareholders at 10 a.m. (Eastern Time) on Thursday, April 23, from the Hyatt Regency Hotel in New Brunswick, N.J. Investors and other interested parties may access the meeting by visiting the Company's website at www.jnj.com, and clicking on the webcast icon. A replay of presentations from the meeting will be available for three months beginning several hours after the live meeting concludes. The replay can be accessed by clicking on "Webcasts/Presentations" in the Investor Relations section of the Company's website.

About Johnson & Johnson

Caring for the world, one person at a time ... inspires and unites the people of Johnson & Johnson. We embrace research and science -- bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 119,000 employees at more than 250 Johnson & Johnson companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.


'/>"/>
SOURCE Johnson & Johnson
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Johnson & Johnson Reports 2009 First-Quarter Results:
2. Trust for Americas Health Supports Recommendations from Robert Wood Johnson Foundation Commission to Build a Healthier America
3. Practice Greenhealth Enters Partnership with Johnson & Johnson for Health Care Sustainability Research and Training
4. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Extended Release (ER) Phase 3 Clinical Data Presented at World Institute of Pain 5th Annual World Congress
5. Johnson & Johnson to Participate in the 29th Annual Cowen & Company Health Care Conference
6. Johnson Institute Transfers Key Programs and Products to Hazelden Foundation
7. Authentidate Holding Corp. Non-executive Chairman F. Ross Johnson Steps Down From Board of Directors
8. Healthcare Businesswomens Association Names Johnson & Johnsons Alex Gorsky, Worldwide Chairman, Surgical Care, as the 2009 HBA Honorable Mentor
9. United States Joins Suits Against Scios and Johnson & Johnson
10. Johnson & Johnson Completes Acquisition of Mentor Corporation
11. Johnson & Johnson Completes Tender Offer for Mentor Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... California Senate ... medical payments per workers’ compensation claim in 2013 and 2014, according to CompScope™ ... Research Institute (WCRI) . , According to the study, medical payments per claim in ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Dianne Michael ... headquartered in Hamilton County, is embarking on a charity drive with the aim ... new homes for orphaned or neglected senior dogs in the Cincinnati region, and ...
(Date:12/8/2016)... Fort Payne, AL (PRWEB) , ... December 08, ... ... enterprise offering insurance and financial consulting services to residential and commercial clients in ... raise awareness and support for Nobis Works. , Since 1977, Nobis Works has ...
(Date:12/7/2016)... Wisconsin (PRWEB) , ... December 07, 2016 , ... Kenall ... extraordinary new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED luminaire ... right amount of light where and when it’s needed. , A 2’ ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... (“Presence”) for a purchase price of approximately $17.4 million (net of the ... revenue is approximately $13.2 million. Headquartered in Barcelona, Spain, Presence is a ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  A new study by a ... use of opioid therapy to treat chronic pain is ... of more harmful consequences, including death. Palliative ... Zankhana Mehta , M.D., authored the study which ... opioid therapy. The study was published in the December ...
(Date:12/8/2016)... 2016  EIP Pharma, LLC ( www.eippharma.com ) ... neflamapimod (previously code named VX-745), with the results ... that demonstrated significant Alzheimer,s disease relevant pharmacological activity.  ... Study 303 (6-week treatment) are the subject of ... (CTAD) scientific conference in San Diego, ...
(Date:12/8/2016)... Mederi Therapeutics Inc . hat die behördliche Zulassung durch die CFDA sowie ... – in China angekündigt. ... ... Live Stretta procedure performed and broadcast during the Chinese Congress ... Union Hospital ...
Breaking Medicine Technology: